Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A potential role for SARS-CoV-2 small viral RNAs in targeting host microRNAs and modulating gene expression. | Sci Rep | 2022 | 36522444 | PubTator, text mining | PubMed |
| Viruses utilize ubiquitination systems to escape TLR/RLR-mediated innate immunity. | Front Immunol | 2022 | 36505476 | PubTator, text mining | PubMed |
| The Significance of COVID-19 Diseases in Lipid Metabolism Pregnancy Women and Newborns. | Int J Mol Sci | 2022 | 36499427 | PubTator, text mining | PubMed |
| Redox stress in COVID-19: Implications for hematologic disorders. | Best Pract Res Clin Haematol | 2022 | 36494143 | PubTator, text mining | PubMed |
| Can CD147 work as a therapeutic target for tumors through COVID-19 infection? | Int J Med Sci | 2022 | 36483594 | PubTator, text mining | PubMed |
| Musculoskeletal complications in long COVID-19: A systematic review. | World J Virol | 2022 | 36483107 | PubTator, text mining | PubMed |
| Discovery of vaccine-like recombinant SARS-CoV-2 circulating in human. | Virol J | 2022 | 36482293 | PubTator, text mining | PubMed |
| Dietary supplements for the management of COVID-19 symptoms. | J Prev Med Hyg | 2022 | 36479480 | PubTator, text mining | PubMed |
| Vaccination with a Zika virus envelope domain III protein induces neutralizing antibodies and partial protection against Asian genotype in immunocompetent mice. | Trop Med Health | 2022 | 36471432 | PubTator, text mining | PubMed |
| An intranasal vaccine targeting the receptor binding domain of SARS-CoV-2 elicits a protective immune response. | Front Immunol | 2022 | 36466882 | PubTator, text mining | PubMed |
| Increased IL-26 associates with markers of hyperinflammation and tissue damage in patients with acute COVID-19. | Front Immunol | 2022 | 36466824 | PubTator, text mining | PubMed |
| Potential antiviral peptides targeting the SARS-CoV-2 spike protein. | BMC Pharmacol Toxicol | 2022 | 36461109 | PubTator, text mining | PubMed |
| Systematic review and meta-analysis of the efficacy and safety of oseltamivir (Tamiflu) in the treatment of Coronavirus Disease 2019 (COVID-19). | PLoS One | 2022 | 36454880 | PubTator, text mining | PubMed |
| Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS-CoV-2. | J Extracell Vesicles | 2022 | 36450704 | PubTator, text mining | PubMed |
| Virome Analysis of Normal and Growth Retardation Disease-Affected Macrobrachium rosenbergii. | Microbiol Spectr | 2022 | 36445118 | PubTator, text mining | PubMed |
| Mucosal delivery of nanovaccine strategy against COVID-19 and its variants. | Acta Pharm Sin B | 2022 | 36438851 | PubTator, text mining | PubMed |
| Performances of four Nucleic Acid Amplification Tests for the identification of SARS-CoV-2 in Ethiopia. | Sci Rep | 2022 | 36434013 | PubTator, text mining | PubMed |
| A Review Pertaining to SARS-CoV-2 and Autoimmune Diseases: What Is the Connection? | Life (Basel) | 2022 | 36431053 | PubTator, text mining | PubMed |
| Evaluation of antiviral activity of Carica papaya leaves against SARS-CoV-2 assisted by metabolomic profiling. | RSC Adv | 2022 | 36425179 | PubTator, text mining | PubMed |
| Computational and comparative investigation of hydrophobic profile of spike protein of SARS-CoV-2 and SARS-CoV. | J Biol Phys | 2022 | 36422744 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=37